is one of the most commonly encountered medical disorders during pregnancy. [4] It is responsible for various adverse obstetric outcomes due to inability to cope with the stress of child birth.
[1] Ranging from cardiac failure, puerperal sepsis, decreased lactation, preterm baby and low birth weight baby, etc. [5] National Anemia Prophylaxis Program revealed that the majority of women were not taking iron folic acid (IFA).
[6] National Family Health Survey (3) showed that IFA coverage as only 57.60% of all pregnant women with 32% in Uttar Pradesh. Lack of effective implementation mechanisms and poor compliance due to ignorance or side-effects are the main impediments in effectiveness of iron supplementation during pregnancy.
Introduction
Anemia is a qualitative or quantitative deficiency of hemoglobin (Hb) or red blood cells (RBC) in circulation leading to reduced oxygen (O 2 ) -carrying capacity of blood to organs and tissues. According to Indian Council of Medical Research, anemia is defined as Hb level of <11 g/dl, mild with Hb of 10-10.9 g/dl, moderate with Hb of 7-10 g/dl and severe with Hb of <7 g/dl.
[1] Nutritional anemia is the most common due to increased demand of iron during pregnancy. [2] In healthy, iron-sufficient women, Hb concentrations change dramatically during pregnancy to accommodate the increasing maternal blood volume and the iron needs of the fetus. [3] It It has been vividly described with etiopathogenesis, clinical features, management, etc., in the ancient texts. [10, 11] The Pitta predominant Doshas are vitiated in Dhatus and as a result of morbidity of Dosha and Dushya (those affected by Dosha), complexion, strength, unctuousness, and other properties of Ojas (Rakta, i.e. blood or Ojas, i.e. immunity itself get diminished [12] ). Thus, it is affected with Alparakta (deficiency of blood), Alpamedas (deficiency of fat), Nihsara (diminished Ojas), Shithilendriya (looseness of body parts) and Vaivarnya (abnormality of complexion) [13] or vitiation of Rakta leads to paleness of skin. [14] Hridya-Spandana (palpitation), Raukshya (dryness of skin), Sweda-Abhawa (absence of sweat) and Shrama (exhaustion) are striking clinical presentations. [15] The ancient commentator stated that though Pitta and Rakta are similar in nature, aggravation of the Pitta does not lead to increase of Rakta, rather it is decreased because of depletion of the nutrient Rasa by Pitta. Similarly, Pitta responsible for complexion produces abnormal color when get vitiated. [16] In Garbhini (pregnant woman), the nutrient Rasa takes three courses -nourishment of her own body, for lactation and for growth of the fetus. [17, 18] Thus, a Garbhini is more prone to suffer from Pandu, especially due to Anuloma-Kshaya of Rasa Dhatu. It also opined that in all types of Pandu, Pitta is the root cause. [19] The disorders of the pregnant woman should be treated with diet and drugs consisting of Mridu Virya (mild potency), Madhura (sweet), Sheeta (cold), etc., properties and which are non-contrary to fetus. [20, 21] This implies that proper nutrition (Poshya Rasa) along with Pitta pacifying measures are the main stream of management in Ayurveda, a key to treat iron deficiency anemia (IDA) as in modern parlance too. Thus, Ayurvedic management with Dhatrilauha, which consisting of all the above-mentioned properties may be considered as an effective way of curing IDA in pregnancy.
Aim and objective
To evaluate the effect of Dhatrilauha in the management of IDA based on the scientific parameters among pregnant patients.
Materials and Methods

Selection of cases
Simple randomized allocation of the 58 pregnant patients selected on the basis of inclusion criteria after the ethical clearance of the research ethical committee of the Institute of Medical Sciences (IMS), Banaras Hindu University (BHU). The patients were selected from the outpatient department of Prasuti Tantra, Faculty of Ayurveda, Sir Sundarlal Hospital, IMS, BHU, Varanasi, Uttar Pradesh, India.
Selection of the test drug
Ayurvedic management is an effective way of curing anemia in general by a large number of Lauha preparations of which Dhatrilauha has been used widely for centuries. [22, 23] Dhatrilauha was selected for two reasons in this study, firstly its classical indication in Pandu Roga, Pitta-Roga and secondly its ingredients which are nutritional, Rasayana (rejuvenating) and Pitta Shamaka (pacifying Pitta) in property. It consists of Dhatri (Amalaki -Emblica officinalis Gaertn.), Yasthimadhu (Glycyrrhiza glabra Linn.), Guduchi (Tinospora cordifolia (Willd) Miers. ex Hook. f. and Thoms.) and Lauha Bhasma (oxide of iron). All ingredients are having Rasayana property. Dhatri is Tridoshahara, specially Pitta Shamaka; [24, 25] Yasthimadhu is Madhura, promotes strength and complexion, pacifies Pitta, Rakta [26] and mild purgative; [27] Guduchi is having Tridoshahara (pacifies Vata, Pitta and Kapha), Balya (strength promoting), Pandu Nashaka (cures anemia), [28] Deepana (appetizer), Pachana (digestive), Krimighna (anthelmintic) and Rakta Vardhaka (hematinic) properties. [29] Lauha Bhasma (Lauha Rajas) is said to be best Pandu Roga Nashaka, [30] Tridoshahara, found in many formulations for the treatment of Pandu and Pitta Roga. [31] [32] [33] Presence of ascorbic acid (vitamin C) in Amalaki has a significant effect on iron bioavailability from cereals and pulses in vitro. [34] Lauha Bhasma also has a significant hematinic and cytoprotective activity, [35] hemoglobin regeneration efficacy. [36] 
Preparation of the test drug
Among the ingredients of the test drug Amalaki, Yasthimadhu and Guduchi in raw form were purchased from Goladinanath (local) Market, Varanasi. Lauha Bhasma was purchased from Dhootpapeshwar Pvt., Ltd., Mumbai. The test drug was prepared referring to Bhaishajya Ratnawali in the Ayurvedic Pharmacy, Department of Rasashastra, IMS; BHU, Varanasi, following standard operating procedure with due permission from the department concern.
Dose selection and drug schedule
The therapeutic dose in this study was calculated to 500 mg [37] in two divided doses after food with normal potable water were given for 45 days with three follow-ups, each of 15 days intervals. Final assessment was done after completion of 45 days and results were statistically analyzed. 
Inclusion criteria
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Assessment of result
The patient was assessed after each follow-up statistically by using Cochran's Q-test and Student's t-test as required of the following parameters:
• The sign and symptoms (weakness, fatigue, palpitation, effort intolerance, breathlessness, heartburn, pallor, and constipation) were assessed before and after treatment with scoring pattern [37] depending on the severities 
Observations
In the present clinical study, 13.8% of the patients were from the age group of 22 and 25 years, 69% were from the semi-urban area, 82.8% were housewife, 50% from lower socioeconomic condition, 84.5% literate, 34.5% were having a family member of 05, 27.6% had last delivery 2 years back. About 77.6% had a chief complaint of which 58.6% had duration of chief complain more than 6 month. 69% had regular bowel habit [ Table 1 ]. In this study, 39.7% of patients were having Pitta predominant Tridoshaja Prakriti [ Table 2 ].
Results
Dhatrilauha was found statistically significant in reducing the majority of sign-symptoms -weakness (Q = 124.6, P < 0.001), fatigue (Q = 105.0, P < 0.001), palpitation (Q = 70.94, P < 0.001), effort intolerance (Q = 95.54, P < 0.001), breathlessness (Q = 92.35, P < 0.001), swelling feet (Q = 52.45, P < 0.001), heartburn (Q = 32.28, P < 0.001), pallor (Q = 143.2, P < 0.001), and constipation (Q = 46.6, P < 0.001) [ Table 3 ].
On diagnostic parameters, it was found statistically highly significant in Hb (t = 10.22, P < 0.001), RBC (t = 5.14, P < 0.001), HCT (t = 9.64, P < 0.001), MCV (t = 10.05, P < 0.001), MCHC (t = 6.30, P < 0.001), RDW (t = 5.34, P < 0.001), mean platelet volume (MPV) (t = 4.96, P < 0.001), serum iron (t = 48.20, P < 0.001), TIBC (t = 19.10, P < 0.001). MCH (t = 0.088, P = 0.930) was found statistically insignificant [ Table 4 ].
Overall therapeutic effect of the test drug [ Figure 1 ] apart from Hb (g%) improvement was found that, out of 19 patients complaining of heartburn, 16 patients got relief and of 26 patients having constipation 24 patients got relief which were found statistically significant.
Discussion
Anemia in pregnancy is defined as a Hb concentration of <11 g/dL. However, in India and most of the other developing countries a lower limit of 10 g/dL is often accepted. It is considered to be the most commonly encountered medical disorder during pregnancy and is responsible for various adverse obstetric outcomes. Ineffective implementation, ignorance or side-effects of conventional iron are the main obstacles in effectiveness of iron supplementation.
Maximum patients were from the age group of 22 and 25 years, the age for the Pitta predominance. Prevalence of the condition among the lower socioeconomic group and in housewife may be due to the devotion only toward the family, no time for self-care, negligence and less education also unawareness toward self.
In Ayurveda, the fertile period of a female is considered normally Pitta predominant. Indulgence of Pitta Vardhaka Ahara (Pitta aggravating diets) such as Amla (sour), Lavana (salt), Katu (pungent), etc., by the pregnant female for fulfillment of Dauhrid (desirous intake) is further vulnerable to vitiate Dhatus by aggravated Pitta. Improper nourishment by Ahara Rasa to the Garbhini is also an important factor. Thus, prevalence of Pandu increases during pregnancy if proper care not taken of especially in relation to diets. In the present study, out of the 58 patients (39.7%) had Pitta predominant Tridoshaja Prakriti (constituents). Therefore, on the basis of observation and etiopathogenesis of Pandu in pregnancy, it could be said that IDA in pregnancy is more close to Pitta predominant Tridoshaja Pandu. In the pathogenesis, the involvement of Dhatus, especially depletion of the nutrient Rasa by vitiated Pitta predominant Doshas and subsequent malnourishment to successive Dhatus have a greater impact on the Ojas as stated in Ayurveda. The Ojas here taken either as blood or the immunity in general by the commentator of Charaka Samhita, Chakrapani. Thus, the principle depends on the two essential strategies namely the drugs those pacify Pitta and diets those nourishes Rasa Dhatu. Both components had been fulfilled by Dhatrilauha in this study.
All the ingredient of Dhatrilauha having Tridoshhara, Rasayana and Rasa-Poshaka (nutritional) properties may be considered the best to maintain the aggravated Pitta. [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] Amalaki, due to Madhura Rasa (sweet taste) and Sheeta Virya (cold potency) reduces Pitta [26, 27] and thus breaks down the main factor in the pathogenesis of Pandu Roga. Further, it contains richest source of vitamin-C, which helps in the absorption of iron thus increases its bioavailability. [36] Yasthimadhu, due to Varnya (complexion promoting) and Pitta pacifying property [28, 29] maintains the normal color of the skin. Guduchi being Tikta Rasa (bitter taste) increases appetite, Krimighna (anti helmentic) and effective against many infections. [30, 31] Lauha Bhasma, the oxide of iron has a direct impact on bodily iron. [32] [33] [34] [35] [36] [37] [38] Thus, the double fold increase in the Pitta aggravation (due to fertile age and Dauhrid) in pregnancy, Dhatrilauha possesses many fold effectiveness in anemia (IDA). This is evidenced with the significant results obtained in the majority of parameters in this study.
The Dhatrilauha was found statistically significant in increasing the Hb level, serum iron and reducing the value of TIBC. Totally 19 patients having complained of acidity, heartburn-related to the gastrointestinal system, of which 16 got relief. A total of 26 patients having constipation, and 24 were relieved from the symptom, may be considered as few advantages over the conventional iron therapy. It showed good tolerability with high acceptance to the pregnant patient without any reported untoward effect.
This work was aimed at providing a new dimension for future large population and multicenter study in the cases of pregnancy anemia so as to utilize this excellent classical drug as a part of National anemia control program to benefit the nation and also to avoid the untoward effect of contemporary iron preparations.
Conclusion
Iron deficiency anemia in pregnancy may be considered under the preview of Pitta Pradhana Pandu Roga in Ayurveda. In this study, a total of 58 pregnant patients were studied with Dhatrilauha and found effective in relieving the majority of sign-symptoms and objective parameters Hb, RBC, HCT, MCV, MCHC, RDW, MPV, serum iron, TIBC. The drug showed good tolerability with high acceptance to the pregnant patient without any reported adverse drug reaction.
